TANG CAPITAL MANAGEMENT LLC — Form 4 insider transactions
TANG CAPITAL MANAGEMENT LLC — Full 13F portfolio →
Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.
| Transaction date | Activity | Security | Shares | Price | Total | Filing |
|---|---|---|---|---|---|---|
| 2026-11-10 | Buy | Boundless Bio, Inc. | 249 | $2.40 | $598 | SEC filing |
| 2026-11-06 | Buy | Boundless Bio, Inc. | 1,700 | $2.40 | $4,080 | SEC filing |
| 2026-11-05 | Buy | Boundless Bio, Inc. | 8,390 | $2.40 | $20,136 | SEC filing |
| 2026-11-04 | Buy | Boundless Bio, Inc. | 517 | $2.40 | $1,241 | SEC filing |
| 2026-11-03 | Buy | Boundless Bio, Inc. | 2,255 | $2.40 | $5,412 | SEC filing |
| 2026-10-27 | Buy | Boundless Bio, Inc. | 10,707 | $2.40 | $25,697 | SEC filing |
| 2026-10-26 | Buy | Boundless Bio, Inc. | 9,606 | $2.38 | $22,862 | SEC filing |
| 2026-10-23 | Buy | Boundless Bio, Inc. | 6,234 | $2.38 | $14,837 | SEC filing |
| 2026-10-22 | Buy | Boundless Bio, Inc. | 5,800 | $2.40 | $13,920 | SEC filing |
| 2026-10-20 | Buy | Boundless Bio, Inc. | 220 | $2.37 | $521 | SEC filing |
| 2026-10-19 | Buy | Boundless Bio, Inc. | 18,279 | $2.33 | $42,590 | SEC filing |
| 2026-10-19 | Buy | Boundless Bio, Inc. | 12,790 | $2.34 | $29,929 | SEC filing |
| 2026-10-16 | Buy | Boundless Bio, Inc. | 118,185 | $2.34 | $276,553 | SEC filing |
| 2026-08-26 | Sell | Boundless Bio, Inc. | 18,300 | $2.97 | $54,351 | SEC filing |
| 2026-07-21 | Buy | Boundless Bio, Inc. | 2,975 | $2.44 | $7,259 | SEC filing |
| 2026-07-20 | Buy | Boundless Bio, Inc. | 1,623 | $2.44 | $3,960 | SEC filing |
| 2026-07-17 | Buy | Boundless Bio, Inc. | 265 | $2.44 | $647 | SEC filing |
| 2026-07-17 | Buy | Fulcrum Therapeutics, Inc. | 50,945 | $3.52 | $179,326 | SEC filing |
| 2026-07-16 | Buy | Fulcrum Therapeutics, Inc. | 116,671 | $3.56 | $415,349 | SEC filing |
| 2026-07-16 | Buy | Boundless Bio, Inc. | 18,491 | $2.44 | $45,118 | SEC filing |
| 2026-07-15 | Buy | Boundless Bio, Inc. | 1,600 | $2.44 | $3,904 | SEC filing |
| 2026-07-14 | Buy | Boundless Bio, Inc. | 43,878 | $2.43 | $106,624 | SEC filing |
| 2026-07-15 | Buy | Fulcrum Therapeutics, Inc. | 107,377 | $3.56 | $382,262 | SEC filing |
| 2026-07-14 | Buy | Fulcrum Therapeutics, Inc. | 75,952 | $3.58 | $271,908 | SEC filing |
| 2026-07-14 | Buy | Fulcrum Therapeutics, Inc. | 53,651 | $3.56 | $190,998 | SEC filing |
| 2026-07-13 | Buy | Fulcrum Therapeutics, Inc. | 12,966 | $3.54 | $45,900 | SEC filing |
| 2026-07-13 | Buy | Boundless Bio, Inc. | 48,211 | $2.42 | $116,671 | SEC filing |
| 2026-07-10 | Buy | Boundless Bio, Inc. | 43,367 | $2.43 | $105,382 | SEC filing |
| 2026-07-09 | Buy | Boundless Bio, Inc. | 7 | $2.48 | $17 | SEC filing |
| 2026-07-08 | Buy | Boundless Bio, Inc. | 14,338 | $2.46 | $35,271 | SEC filing |
| 2026-07-07 | Buy | Boundless Bio, Inc. | 15,810 | $2.48 | $39,209 | SEC filing |
| 2026-07-06 | Buy | Boundless Bio, Inc. | 27,062 | $2.49 | $67,384 | SEC filing |
| 2026-07-02 | Buy | Boundless Bio, Inc. | 9,821 | $2.49 | $24,454 | SEC filing |
| 2026-07-01 | Buy | Boundless Bio, Inc. | 71,612 | $2.49 | $178,314 | SEC filing |
| 2026-06-30 | Buy | Boundless Bio, Inc. | 100 | $2.50 | $250 | SEC filing |
| 2026-06-30 | Buy | Boundless Bio, Inc. | 25,930 | $2.54 | $65,862 | SEC filing |
| 2026-06-29 | Buy | Boundless Bio, Inc. | 777 | $2.48 | $1,927 | SEC filing |
| 2026-06-29 | Buy | Boundless Bio, Inc. | 63,985 | $2.47 | $158,043 | SEC filing |
| 2026-06-26 | Buy | Boundless Bio, Inc. | 134 | $2.54 | $340 | SEC filing |
| 2026-06-26 | Buy | Boundless Bio, Inc. | 75,047 | $2.55 | $191,370 | SEC filing |
| 2026-06-25 | Buy | Boundless Bio, Inc. | 510 | $2.56 | $1,306 | SEC filing |
| 2026-06-25 | Buy | Boundless Bio, Inc. | 145,880 | $2.48 | $361,782 | SEC filing |
| 2026-06-02 | Buy | Aurinia Pharmaceuticals Inc. | 206,005 | $15.28 | $3,147,756 | SEC filing |
| 2026-06-01 | Buy | Aurinia Pharmaceuticals Inc. | 99 | $15.34 | $1,519 | SEC filing |
| 2026-06-01 | Buy | Aurinia Pharmaceuticals Inc. | 343,521 | $15.28 | $5,249,001 | SEC filing |
| 2026-05-29 | Buy | Aurinia Pharmaceuticals Inc. | 262,682 | $15.31 | $4,021,661 | SEC filing |
| 2026-05-29 | Buy | Aurinia Pharmaceuticals Inc. | 2,299 | $15.35 | $35,290 | SEC filing |
How Form 4 differs from 13F
13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.